Sensex & Nifty Hold Gains; Midcap Index Hits Record High | Aurobindo Pharma up 2%

After opening the session on a strong note, positive momentum continued in the market, driven by a rally in banks & midcaps. The Nifty midcap index clocked a record high figure.
Share price of Aurobindo Pharma rose 2 percent intraday Tuesday on USFDA approval for Meropenem Injection.
The company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Meropenem Injection 500 mg/ vial and 1g/vial. For Any Information visit : www.paceresearchindia.com and call : 8817774774